Lipid Peroxidation Analytical Core

脂质过氧化分析核心

基本信息

项目摘要

CORE C PROJECT SUMMARY The overall goal of this program project is to test the contribution of changes in high density lipoprotein (HDL) function in human disease, specifically atherosclerosis. One of the major hypotheses tested is that the lipid peroxidation that occurs during various condition that increase the risk for atherosclerosis (e.g. familial hypercholesterolemia and chronic kidney disease) causes HDL to become modified by reactive lipid dicarbonyls and that these modifications markedly alter HDL function. This core will provide synthetic versions of these reactive dicarbonyls to project investigators so that they can test the effects of HDL modification. This core will also provide synthetic compounds that act as dicarbonyl scavengers and that can be used in both cultured cells, in animals, and in humans to block the reaction of dicarbonys with proteins and phosphatidylethanolamine. These scavengers are useful both to test the contribution of these dicarbonyls and as potential medicinal agents. Finally, this core will measure dicarbonyl adducts on proteins and phosphatidylethanolamine. Aim 1: Synthesize IsoLG and other dicarbonyls for testing in cultured cell and animal models. Aim 2: Synthesize dicarbonyl scavengers for testing in cultured cell and animal models. Aim 3: Measure the amounts of dicarbonyl modified proteins and phosphatidylethanolamines that are formed in tissue samples and fluids in animal models and humans with disease.
Core c项目总结

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

SEAN Stephen DAVIES其他文献

SEAN Stephen DAVIES的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('SEAN Stephen DAVIES', 18)}}的其他基金

Lipid Peroxidation Analytical Core
脂质过氧化分析核心
  • 批准号:
    10327713
  • 财政年份:
    2014
  • 资助金额:
    $ 24.65万
  • 项目类别:
Modification of HDL and Macrophage Function in Atherosclerosis
动脉粥样硬化中 HDL 和巨噬细胞功能的改变
  • 批准号:
    10544067
  • 财政年份:
    2014
  • 资助金额:
    $ 24.65万
  • 项目类别:
Lipid Peroxidation Analytical Core
脂质过氧化分析核心
  • 批准号:
    10089338
  • 财政年份:
    2014
  • 资助金额:
    $ 24.65万
  • 项目类别:
Modification of HDL and Macrophage Function in Atherosclerosis
动脉粥样硬化中 HDL 和巨噬细胞功能的改变
  • 批准号:
    10089343
  • 财政年份:
    2014
  • 资助金额:
    $ 24.65万
  • 项目类别:
Modification of HDL and Macrophage Function in Atherosclerosis
动脉粥样硬化中 HDL 和巨噬细胞功能的改变
  • 批准号:
    10327718
  • 财政年份:
    2014
  • 资助金额:
    $ 24.65万
  • 项目类别:
Therapeutically Modified Gut Bacteria for Treatment of Obesity
用于治疗肥胖症的治疗性修饰肠道细菌
  • 批准号:
    8843716
  • 财政年份:
    2013
  • 资助金额:
    $ 24.65万
  • 项目类别:
Therapeutically Modified Gut Bacteria for Treatment of Obesity
用于治疗肥胖症的治疗性修饰肠道细菌
  • 批准号:
    9042948
  • 财政年份:
    2013
  • 资助金额:
    $ 24.65万
  • 项目类别:
Therapeutically Modified Gut Bacteria for Treatment of Obesity
用于治疗肥胖症的治疗性修饰肠道细菌
  • 批准号:
    8656665
  • 财政年份:
    2013
  • 资助金额:
    $ 24.65万
  • 项目类别:
Therapeutically Modified Gut Bacteria for Treatment of Obesity
用于治疗肥胖症的治疗性修饰肠道细菌
  • 批准号:
    8481874
  • 财政年份:
    2013
  • 资助金额:
    $ 24.65万
  • 项目类别:
Transformed Probiotic Bacteria for Treatment of Chronic Diseases
用于治疗慢性疾病的转化益生菌
  • 批准号:
    7431222
  • 财政年份:
    2007
  • 资助金额:
    $ 24.65万
  • 项目类别:

相似海外基金

CORE--TRANSGENIC ANIMALS AND ATHEROSCLEROSIS MEASUREMENTS
核心——转基因动物和动脉粥样硬化测量
  • 批准号:
    6353520
  • 财政年份:
    2000
  • 资助金额:
    $ 24.65万
  • 项目类别:
CORE--TRANSGENIC ANIMALS AND ATHEROSCLEROSIS MEASUREMENTS
核心——转基因动物和动脉粥样硬化测量
  • 批准号:
    6202169
  • 财政年份:
    1999
  • 资助金额:
    $ 24.65万
  • 项目类别:
CORE--TRANSGENIC ANIMALS AND ATHEROSCLEROSIS MEASUREMENTS
核心——转基因动物和动脉粥样硬化测量
  • 批准号:
    6109433
  • 财政年份:
    1998
  • 资助金额:
    $ 24.65万
  • 项目类别:
Gene Regulation of Atherosclerosis in Diabetic Animals
糖尿病动物动脉粥样硬化的基因调控
  • 批准号:
    6948837
  • 财政年份:
    1997
  • 资助金额:
    $ 24.65万
  • 项目类别:
CORE--TRANSGENIC ANIMALS AND ATHEROSCLEROSIS MEASUREMENTS
核心——转基因动物和动脉粥样硬化测量
  • 批准号:
    6241568
  • 财政年份:
    1997
  • 资助金额:
    $ 24.65万
  • 项目类别:
Gene Regulation of Atherosclerosis in Diabetic Animals
糖尿病动物动脉粥样硬化的基因调控
  • 批准号:
    6543490
  • 财政年份:
    1997
  • 资助金额:
    $ 24.65万
  • 项目类别:
Gene Regulation of Atherosclerosis in Diabetic Animals
糖尿病动物动脉粥样硬化的基因调控
  • 批准号:
    6654928
  • 财政年份:
    1997
  • 资助金额:
    $ 24.65万
  • 项目类别:
Gene Regulation of Atherosclerosis in Diabetic Animals
糖尿病动物动脉粥样硬化的基因调控
  • 批准号:
    6784143
  • 财政年份:
    1997
  • 资助金额:
    $ 24.65万
  • 项目类别:
SMOOTH MATRICES AS A MODEL FOR INJURY IN ATHEROSCLEROSIS /HUMAN,ANIMALS
平滑基质作为动脉粥样硬化损伤模型/人类、动物
  • 批准号:
    3920329
  • 财政年份:
  • 资助金额:
    $ 24.65万
  • 项目类别:
SMOOTH MATRICES AS A MODEL FOR INJURY IN ATHEROSCLEROSIS /HUMAN,ANIMALS
平滑基质作为动脉粥样硬化损伤模型/人类、动物
  • 批准号:
    3943102
  • 财政年份:
  • 资助金额:
    $ 24.65万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了